Skip to main content

Blog

CDCC Spotlight: Children’s Hospital Los Angeles

...

Entrada Therapeutics starts dosing in ENTR-601-44 Phase 1 trial

...

RSV, COVID, and Flu – oh my!

...

PTC Therapeutics Announces Negative European Medicines Agency Opinion Regarding Full Authorization of Translarna

...

Game Day Tips for Coach to Cure MD 2023

...

Duchenne Action Month: Ways to get involved with PPMD

...

CDCC Spotlight: Arkansas Children’s Hospital

...

FibroGen Announces Topline Data from Phase 3 LELANTOS-2 Study

...

Breaking barriers together, this Duchenne Action Month and every day

...

WATCH: Advocating for Access: Navigating Approved Therapies in Duchenne (Webinar Recording)

...